ARS Pharmaceuticals Inc. (SPRY)
NASDAQ: SPRY
· Real-Time Price · USD
15.09
-0.30 (-1.95%)
At close: Jun 16, 2025, 12:35 PM
ARS Pharmaceuticals Revenue
ARS Pharmaceuticals reported an annual revenue of $89.15M, reflecting a 297063.33% growth. For the quarter ending March 31, 2025, ARS Pharmaceuticals generated $7.97M in revenue.
Revenue (ttm)
$89.15M
Revenue Growth
297063.33%
Price / Sales Ratio
11.47
Revenue / Employee
$575.15K
Employees
155
Market Cap
1.48B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|